a weak trendp = 0.07
The frequency of the primary end point through 12 months was similar among study groups, with a weak trend toward a reduced risk in the prasugrel group after 12 months ( p = 0.07 for interaction).
The frequency of the primary end point through 12 months was similar among study groups, with a weak trend toward a reduced risk in the prasugrel group after 12 months ( p = 0.07 for interaction).